In contrast, in COVID-19, we observed a tendency towards elevated frequencies of CD39+ cells of all three cytotoxic lymphocyte subsets, although these trends did not reach statistical significance, most likely due to the small sample size (Figure 2E–H). This evidence concerns the gene ENTPD1 and COVID-19.